Coronary artery ectasia: new insights into pathophysiology, diagnosis, and treatment

被引:43
作者
Eitan, Amnon [1 ]
Roguin, Ariel [1 ,2 ]
机构
[1] Rambam Med Ctr, Cardiol Dept, 7 Efron St,POB 9602, IL-31096 Haifa, Israel
[2] Technion Israel Inst Technol, Rappaport Fac Med, Dept Med, Haifa, Israel
关键词
angina pectoris; angiography; coronary artery disease; coronary artery ectasia; prognosis; stenting; treatment; ACUTE MYOCARDIAL-INFARCTION; POLYTETRAFLUOROETHYLENE-COVERED STENT; INTRAVASCULAR ULTRASOUND; MATRIX METALLOPROTEINASE-3; CLINICAL-SIGNIFICANCE; AORTIC-ANEURYSMS; KAWASAKI-DISEASE; PREVALENCE; MANAGEMENT; FLOW;
D O I
10.1097/MCA.0000000000000379
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronary artery ectasia (CAE) is defined as a segment of the coronary artery that has a diameter of more than 1.5 times the normal adjacent segments. It was described many years ago, but many aspects of this phenomenon are still unknown. It can be found in 1.2-2% of patients referred for coronary angiography. Risk factors are similar to atherosclerosis, but not in all patients. Histology shows extensive destruction of the musculoelastic elements, with marked degradation of the medial collagen and elastin fibers with disruption of the internal and external elastic lamina. These patients have abnormal levels of matrix metalloproteinases and other related proteins. Yet, the actual etiology of CAE is still unknown. Advances in new and improved imaging modalities such as CT and magnetic resonance angiography enable easier and more accessible diagnosis and evaluation. Treatment is aimed mostly at common cardiovascular risk factors. In small series, CAE was associated with worse prognosis. Anticoagulation was never examined in large trials. Nitrates worsen the flow and should not be administered. Interventional treatments are also an option, but a challenging one. This review presents an update on the current knowledge on CAE. Coron Artery Dis 27:420-428 Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:420 / 428
页数:9
相关论文
共 57 条
  • [1] Altered coronary flow properties in diffuse coronary artery ectasia
    Akyürek, Ö
    Berkalp, B
    Sayin, T
    Kumbasar, D
    Kervancioglu, C
    Oral, D
    [J]. AMERICAN HEART JOURNAL, 2003, 145 (01) : 66 - 72
  • [2] Relation of coronary artery ectasia to diabetes mellitus
    Androulakis, AE
    Andrikopoulos, GK
    Kartalis, AN
    Stougiannos, PN
    Katsaros, AA
    Syrogiannidis, DN
    Tapanlis, EN
    Stefanadis, C
    Kallikazaros, IE
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (09) : 1165 - 1167
  • [3] Pathogenetic mechanisms of coronary ectasia
    Antoniadis, Antonios P.
    Chatzizisis, Yiannis S.
    Giannoglou, George D.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 130 (03) : 335 - 343
  • [4] Patterns of coronary artery ectasia and short-term outcome in acute myocardial infarction
    Boles, Usama
    Zhao, Ying
    Rakhit, Roby
    Shiu, Man Fi
    Papachristidis, Alexandros
    David, Santosh
    Koganti, Sudheer
    Gilbert, Timothy
    Henein, Michael Y.
    [J]. SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2014, 48 (03) : 161 - 166
  • [5] Pure coronary ectasia differs from atherosclerosis: Morphological and risk factors analysis
    Boles, Usama
    Zhao, Ying
    David, Santhosh
    Eriksson, Peter
    Henein, Michael Y.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 155 (02) : 321 - 323
  • [6] Boyer N, 2014, J INVASIVE CARDIOL, V26, P283
  • [7] Polytetrafluoroethylene-covered stent and coronary artery aneurysms
    Briguori, C
    Sarais, C
    Sivieri, G
    Takagi, T
    Di Mario, C
    Colombo, A
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2002, 55 (03) : 326 - 330
  • [8] Coronary artery ectasia is related to coronary slow flow and inflammatory activation
    Brunetti, Natale Daniele
    Salvemini, Giuseppe
    Cuculo, Andrea
    Ruggiero, Antonio
    De Gennaro, Luisa
    Gaglione, Antonio
    Di Biase, Matteo
    [J]. ATHEROSCLEROSIS, 2014, 233 (02) : 636 - 640
  • [9] Buikema H, 1996, EUR HEART J, V17, P787
  • [10] Campanile A, 2014, MINERVA CARDIOANGIOL, V62, P327